Transaction #877 · Form 4 · 0001193125-25-241424

GoodRx Holdings, Inc. · Conversion · Class A Common Stock

GoodRx Holdings, Inc. · Transacted October 14, 2025 · Filed October 16, 2025

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for GoodRx Holdings, Inc. records a conversion involving Class A Common Stock on October 14, 2025. The reported quantity was 8,881,362. The filing date is October 16, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001809519
Security type
Non-derivative
Acquisition type
Conversion · Code C
Quantity acquired
8,881,362
Reported price
Not reported · See footnotes
Reference value
Not reported
Currency
Currency not specified
Ownership
Indirect
Holdings after transaction
8,881,362
Ownership description
By Spectrum Equity VII, L.P.
SEC acceptance time
Oct 16, 2025, 4:14 PM EDT
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

GDRX · Nasdaq

This transaction is not mapped to a specific company listing.

Filing footnotes & remarks

F1
Represents the conversion of the Issuer's Class B Common Stock ("Class B Shares") into shares of the Issuer's Class A Common Stock (the "Class A Shares") on a one-for-one basis.
F2
The general partner of Spectrum Equity VII, L.P. ("SE VII") is Spectrum Equity Associates VII, L.P. ("Spectrum Equity Associates"). The general partner of each of Spectrum VII Investment Managers' Fund, L.P. ("Spectrum VII Investment Managers' Fund"), Spectrum VII Co-Investment Fund L.P. ("Spectrum VII Co-Investment Fund"), and Spectrum Equity Associates is SEA VII Management, LLC ("Management LLC"). Brion B. Applegate, Christopher T. Mitchell, Victor E. Parker, Jr., Benjamin C. Spero, Ronan Cunningham, Stephen M. LeSieur, Brian Regan and Michael W. Farrell may be deemed to share voting and dispositive power over the securities held by SE VII, Spectrum VII Investment Managers' Fund and Spectrum VII Co-Investment Fund. Each of these individuals disclaims beneficial ownership of such securities, except to the extent of their pecuniary interest, if any.
F3
Spectrum Equity VII, L.P. made a pro rata distribution of 8,881,362 shares of Class A Shares to its general partner and limited partners for no consideration on October 14, 2025.
F4
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.000 to $4.005 per share, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.